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ABSTRACT
Introduction: At the end of pregnancy, the amniotic fluid (AF) depends basically on renal
function, corresponding to fetal urine. Changes in AF, especially oligohydramnios, are reported in
association with fetal hydronephrosis (FH). The experimental model using adriamycin in pregnant
female rats has a teratogenic effect and has been classically employed to study esophageal atresia.
Nevertheless, adriamycin promotes FH with high frequency as well. In the present study, using this
animal model, we tried to identify the incidence and microscopic changes of FH, as well as its corre-
lation with AF weight.
Materials and Methods: Eight Spreague-Dawley pregnant female rats received adriamycin
2.2 mg/kg on the 8th and 9th gestational days (considering term gestation = 22 days). Those fetuses
that received adriamycin (Adriamycin Group) were compared with fetuses from 2 female rats (Con-
trol Group), which received 0.9% saline solution. On the 21.5 gestational day, the fetuses were col-
lected by cesarean incision, sacrificed, and examined for macro and microscopic changes in kidneys
and ureters. Fetuses with bilateral hydronephrosis formed the Hydronephrosis Group. AF weight was
determined as well.
Results: Hydronephrosis occurred in 70 (95%) of the 74 fetuses in the adriamycin group
against none of the 21 fetuses from the control group. The amniotic fluid weight was increased in the
adriamycin group in relation to the control group (p < 0.001). The histomorphometric study revealed
dilation of the renal pelvis and reduction of renal parenchyma in the hydronephrosis group in relation
to the control group. Severe cortical atrophy, cortical tubular atrophy and medullar atrophy were
observed in the hydronephrosis group.
Conclusions: Slight renal lesions were in agreement with changes in AF weight, since they
suggest that there was production of urine with the maintenance of AF.
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INTRODUCTION
The amniotic fluid (AF) at the end of preg-
nancy depends basically on renal function, corre-
sponding to the fetal urine (1). Changes in AF con-
cerning volume, osmolarity and solute partition are
reported in association with fetal hydronephrosis (FH)
(2-4).
FH is characterized by prenatal dilation of
the renal pelvis. Generally, it is associated with de-
creased urinary flow, structural changes in renal pa-
renchyma and impairment of renal function (5,6). The
clinical manifestation of FH is variable, presenting
an unfavorable outcome when it is bilateral or is as-
sociated with decrease in AF (oligohydramnios)
(2,7,8). Moreover, the prenatal assessment of AF has
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a predictive value on the prognosis of the newborn
(7,8).
The experimental model using adriamycin
in pregnant female rats has a teratogenic effect and
has been classically employed to study esophageal
atresia. However, adriamycin promotes other fetal
morphologic changes, with FH being the urinary
anomaly that occurs with higher frequency (9-11).
Much has been described about gastrointestinal
changes in the adriamycin model (12), however, little
has been studied about renal changes and their cor-
relation with AF.
In the present study, we tried to identify the
feasibility of using adriamycin for the microscopic
study of FH, aiming to correlate renal microscopic
changes with AF weight (AFw).
MATERIALS AND METHODS
Eight Spreague-Dawley pregnant female rats,
weighting between 250 and 300 g, received intra-peri-
toneal adriamycin 2.2 mg/kg on the 8th and 9th ges-
tational days (term = 22 days). The fetuses that re-
ceived adriamycin (Adriamycin Group) were com-
pared with fetuses from 2 female rats (Control Group)
that had received 0.9% saline solution on the same
gestational days.
On the day 21.5 of pregnancy, the rats under-
went a cesarean incision and the amniotic sac was
integrally extracted and weighted (ASw) in a preci-
sion balance. The amniotic sac was then excised and
the fetus (Fw), the placenta and the amniochorionic
membranes (PMw) were weighted separately. The
AFw was obtained through the formula: AFw = ASw
- (Fw + PMw) in grams.
Then the fetuses were collected, sacrificed
and examined for macroscopic changes in kidneys
and ureters, bladder changes, and presence of proxi-
mal digestive atresias. Fetuses from the adriamycin
group with bilateral hydronephrosis formed the Hy-
dronephrosis Group.
The abdominal region with the retroperito-
neal cavity of fetuses, containing kidneys and ure-
ters, was fixed in formaldehyde 4% and included in
paraffin. Semi-serial coronal histological sections
were obtained, measuring 5 µm, equidistant in 20 µm
between the anterior and posterior renal limits. Sec-
tions were stained with hematoxylin and eosin.
Histomorphometric Study and Qualitative
Microscopic Analysis
The fetal kidneys from the hydronephrosis
group and the control group were compared under
light microscopy. Images obtained by microscopy
were transmitted to the computer via digital camera.
Subsequently, they were dimensioned using Image-
Pro Plus 4.1 software (Media Cybernetics 1999),
which allows the gauging of linear measures and area
after manually defining 2 points and the perimeter,
respectively. The micrometric scale was previously
defined by a calibration file, according to the
microscope’s objective lens.
With a X20 magnification, the 3 consecutive
sections of each left kidney were determined, where
the diameters of the ureteropelvic junction were larg-
est. In these sections, the diameter of the ureteropel-
vic junction, the mean parenchymal thickness, the area
of the renal pelvis, and the area of renal parenchyma
were measured, and the relationships between paren-
chyma and pelvis were established (Figure-1).
The histological changes of pelvic epithelium,
proximal ureter and kidney (epithelial, mesenchymal,
epithelial-mesenchymal, obstructive and inflamma-
tory) were qualitatively analyzed according to what
is described in the literature for the model of obstruc-
tive hydronephrosis (13,14).
Statistical Analysis
The statistical analysis of weights, with com-
parisons between the adriamycin and control groups,
and the histomorphometric measures, with compari-
sons between the hydronephrosis and control groups,
was performed through Mann-Whitney non-paramet-
ric test, considering the difference as significant for
p < 0.05 and highly significant for p < 0.001.
RESULTS
Pregnancy was confirmed in 10 female rats,
with 8 forming the adriamycin group and 2 the con-
trol group. A total of 81 fetuses were obtained in the
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adriamycin group, of which 74 (91%) were alive and
7 (9%) dead (4 were reabsorbed and 3 were hydro-
pic). In the control group, 21 fetuses were obtained,
all alive.
In the adriamycin group, hydronephrosis (Fig-
ure-2) was observed in 70 out of 74 fetuses (95%), in
addition to other malformations. In the 21 fetuses from
the control group, the malformations under study were
not observed (Table-1).
ASw, Fw and PMw were decreased and AFw
was increased in the adriamycin group in relation to
the control group (p < 0.001) (Table-2).
The histomorphometric study revealed pel-
vic dilation and reduction of renal parenchyma in the
hydronephrosis group when compared with the con-
trol group (p < 0.001) (Table-3).
The qualitative microscopic analysis of the
kidneys in both groups demonstrated the capacity of
distinguishing between medullar and cortical in a
lower magnification (X20) and the existence of neph-
rogenic zone, composed by immature glomeruli (Fig-
ure-3). In the hydronephrosis group, we observed se-
Figure 1 – Scheme used for performing the histomorphometric
examination. 2-headed arrows indicate linear measurements.
A1 = area of renal parenchyma and A2 = area of renal pelvis.
Table 1  –  Frequency of malformations in the adriamycin
group.
Malformation
Hydronephrosis
 - Bilateral
 - Unilateral
Duodenal Atresia
Esophageal Atresia
Bladder Hypoplasia
70 (95)
64 (87)
6   (8)
68 (92)
67 (91)
62 (84)
Frequency (%)
Figure 2 – Macroscopic comparison between a normal kidney
from the control group (left) with hydronephrotic kidney from the
adriamycin group (right). The ureters are delimited, showing
dilation in the adriamycin group.
*p < 0.001; ASw = weight of amniotic sac; Fw = fetal weight; PMw = weight of placenta and amniotic membranes; AFw = weight
of amniotic fluid.
Table 2  –  Comparison of weights. Mean, standard deviation and interval.
Weights
ASw (g)
Fw (g)
PMw (g)
AFw(g)
Adriamycin Group
5.23* (± 0.56); 0.38 – 6,51
3.39* (± 0.43); 2.12 – 4.36
0.95* (± 0.16); 0.35 – 1.62
0.90* (± 0.33); 0.08 – 2.34
Control Group
5.96 (± 0.27); 5.27 – 6.63
4.27 (± 0.18); 3.88 – 4.62
1.11 (± 0.14); 0.67 – 1.50
0.58 (± 0.18); 0.19 – 0.97
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vere cortical atrophy and tubular cortical atrophy; as
well as moderate caliceal dilation, moderate to se-
vere cystic tubular change and slight mesangial hy-
perplasia, whereas in the control group such changes
were not observed (Figure-4).
The search for microscopic changes in pel-
vis and ureter revealed severe pelvic dilation with flat-
tening of the epithelial cells, and dilation and tortu-
osity of the proximal ureter in the hydronephrosis
group. On the other hand, no changes were observed
in the ureteral epithelium, which was similar to the
control group.
COMMENTS
Adriamycin acts on the S-phase of the cell
cycle, inhibiting topoisomerase II and consequently
Figure 4 – Microscopic comparison between a normal kidney
from the control group (left) with hydronephrotic kidney from the
hydronephrosis group (right). Note mature (arrows) and imma-
ture (arrowheads) glomeruli in the control group. In the hydro-
nephrosis group, we can see medullar and cortical atrophy and
cystic tubular dilation (arrow), (HE, X200).
Figure 3 – Microscopic comparison between a normal kidney
from the control group (left) with hydronephrotic kidney from the
hydronephrosis group (right). The cortical-medullar limit is
shown (arrowheads). Note the atrophy in the hydronephrosis
group, (HE, X20).
DNA synthesis (15). This inhibition induces cell
apoptosis, and is the potential molecular cause of the
malformations detected, deriving mostly from a fail-
ure in the embryologic development of mesoderma
(16).
The decrease in ASw, Fw and PMw in the
adriamycin group in relation to the control group is
due to the drug’s deleterious effects, either by its pri-
mary action, or by the repercussions from the mal-
formations it induces (9,10).
The frequency of detected malformations was
similar to those found by other authors who used
adriamycin (9-11,17).
Fetuses with serious renal defects leading to
intra-uterine urinary retention evolve with oligohy-
Table 3 – Comparison of histomorphometric measures. Mean, standard deviation and interval.
Relationship  Hydronephrosis Group       Control Group
Parenchymal Thickness
    x  UPJ Diameter 0.68* (± 0.25); 0.37 – 1.52 1.36 (± 0.30); 0.81 – 2.10
Parenchymal Area x
    Pelvic Area 1.83* (± 0.84); 0.83 – 4.35 5.83 (± 2.44); 2.81 – 12.13
*p < 0.001; UPJ = ureteropelvic junction
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dramnios, due to the relation between the production
of fetal urine and a proper amount of AF (3,7). De-
spite bilateral FH occurring in 87% of fetuses in the
adriamycin group, there was an increase in AFw in
relation to the control group (p < 0.0001). However,
a bilateral FH occurred in association with 100% of
digestive atresias. Such atresias, especially proximal
ones, impair the deglutition of AF, as well as its ab-
sorption in the gastrointestinal tract, and may lead to
polyhydramnios (18).
The association between these anomalies,
intestinal atresias and FH, which have a contrary ef-
fect on AFw, and other potential causes of oligohy-
dramnios can make results controversial. However,
the present study showed that the ability of forming
urine, and consequently AF by the fetal kidney was
preserved, since there was no decrease in the AFw.
Hence, it is not important to say that AFw increased,
but that it did not decrease, since little AF would in-
dicate low production of fetal urine.
Merei et al. (2001) studied urinary malfor-
mations in the adriamycin model and concluded that
the ureters would present a blind end, producing hy-
dronephrotic fetal kidneys and altering the normal
development of urinary bladder (11). In order to ex-
plain the increase in AF that occurs concomitantly in
blind-ending ureters, extra-renal compensatory
mechanisms would be required.
Liu & Hutson (2000), while studying urogeni-
tal malformations in the same model, concluded that
the ureters might communicate with the urethra in
male fetuses, and with the urogenital sinus in female
fetuses, through an uretero-ureteral or uretero-uro-
genital fistula, respectively (19). Thus, urinary flow
would occur, which would allow for a proper mainte-
nance of AF amount. The occurrence of FH non-as-
sociated with oligohydramnios is suitable with the
explanations proposed by Liu & Hutson (2000), since
it may be the indirect result of passage of urine to the
amniotic cavity (19).
In relation to bladder development, the oc-
currence of 84% of bladder hypoplasia observed in
the present study could be explained both by the lack
of filling due to fistula between ureter and urethra or
urogenital sinus and by the presence of blind-ending
ureter (11,19).
Liu et al. (1999) studied bladder development,
using adriamycin and verified that the 7th gestational
day is the critical time when the drug administration
causes bladder agenesis. Bladder hypoplasia observed
in the present study, considering that the drug was
administered on the 8th and 9th days, must be conse-
quent to ureteral defects or represent an effectively
distinct anomaly from that observed by the same au-
thor (20).
The histomorphometric study revealed in-
crease in the ureteropelvic junction (UPJ) diameter
and in pelvic area, and decrease of parenchymal thick-
ness and parenchymal area in the hydronephrosis
group when compared with the control group. The
parenchyma/pelvis relationships were decreased to
half in the hydronephrosis group in relation to the
control group, when we used linear measures de-
creased to one third, when area measurements were
used. These results objectively confirm the pelvic
dilation and decrease in renal parenchyma observed
in kidneys with hydronephrosis.
In models of surgically created hydroneph-
rosis, we detected epithelial, epithelial-mesenchymal,
obstructive and inflammatory changes, including at-
rophy, dysplasia, fibrosis and changes in the renal de-
velopment (3,13,14).
Microscopic findings in the present study
are milder than the ones reported in those works,
being restricted to the mechanical repercussion of
urine retention, which is characterized by dilation
of ureter, pelvis and ducts, and to secondary mass
changes, such as atrophy of cortex and medulla.
Moreover, no inflammatory or developmental
changes were observed.
Other changes were expected in addition to
dilation, since urine retention can be associated with
renal damage and impair its normal differentiation
(6,14). However, the microscopic findings are in
agreement with other findings relative to AFw, which
indirectly revealed production of fetal urine.
CONCLUSION
The experimental model of induction by
adriamycin showed to be feasible for the microscopic
study of fetal hydronephrosis. The microscopic
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changes, despite being milder than the lesions de-
scribed for surgically produced fetal hydronephrosis,
were in agreement with amniotic fluid weight, since
they enabled the production of urine with maintenance
of the amniotic fluid.
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